Background: Plants rich in essential oils belong to more than 50 families, including Asteraceae, Rutaceae, and Lamiaceae. These plants are widely used in food, traditional and modern medicine, perfumery, cosmetics, and pharmaceutical industries. Approximately 3,000 types of essential oils have been identified, of which more than 300 are utilized for industrial and commercial purposes. Essential oils exhibit antimicrobial, anti-inflammatory, anticancer, cytotoxic, and antioxidant activities and are therefore widely applied in medical research. In Mongolia, the extreme climate, distinct ecological regions, and the prevalence of pastoral livestock husbandry provide a scientific basis for investigating essential oil–containing plants, their chemical composition, and biological activities. Among them, Juniperus Sabina L. is of particular theoretical and practical interest. Aim: To determine the non-toxic dose of essential oil extracted from Juniper Sabina L. on neural cells. Materials and Methods: This study was conducted at the Institute of Bio-Medicine, MNUMS. Ethical approval was obtained from the Research Ethics Committee of MNUMS (Meeting date: November 21, 2025; Protocol No. 2025-26/0301). BV2 microglial and N2a neuronal cell lines were cultured under standard conditions at 37°C in a 5% CO₂ incubator. Cells were maintained in appropriate culture media, and their growth and morphology were monitored microscopically before experimentation. Cell viability was assessed using the MTT assay. BV2 microglial cells were seeded into 96-well plates at a density of 2×10⁴ cells/well and incubated for 24 hours. Essential oil was added at concentrations ranging from 50–500 µg/mL and incubated for an additional 24 hours. After treatment, MTT reagent was added and incubated for 3 hours. The resulting formazan crystals were dissolved in dimethyl sulfoxide (DMSO), and absorbance was measured at 630 nm. Cell viability was calculated based on absorbance values to determine the non-toxic concentration of the essential oil. Result: The cytotoxic effects of the essential oil were evaluated in BV2 microglial and N2a neuronal cells using the MTT assay. In N2a neuronal cells, concentrations of 50, 100, 200, and 300 µg/mL did not significantly affect cell viability, whereas 400 and 500 µg/mL reduced cell viability, indicating cytotoxic effects. Conclusion According to MTT assay results, the essential oil of Juniperus sabina showed no cytotoxic effect on N2a neuronal cells at concentrations of 50, 100, 200, and 300 µg/mL, while cytotoxic effects were observed at 400 and 500 µg/mL. In BV2 microglial cells, concentrations of 50, 100, and 200 µg/mL were non-toxic, whereas concentrations above 300 µg/mL exhibited cytotoxic effects.

Background: The genus Thalictrum belongs to the family Ranunculaceae Juss. and comprises approximately 200 species distributed worldwide. Most species occur in temperate regions, although a few are also found in lowland areas. Approximately 43 species of Thalictrum have traditionally been used as medicinal raw materials due to their notable therapeutic properties and reported efficacy. These plants have traditionally been used to treat a wide range of conditions, including infectious diseases, nervous system disorders, joint diseases, intestinal inflammation, gingivitis, tumors, jaundice, pneumonia, and other pulmonary inflammatory conditions. They have also been used for wound healing, reducing fever, treating gastric and duodenal ulcers, managing eye disorders and headaches, restoring physical strength, promoting diuresis, alleviating digestive disturbances, stimulating intestinal peristalsis to facilitate bowel movements, supporting recovery after illness, and treating snakebites. Phytochemical investigations have revealed that Thalictrum species contain diverse bioactive constituents, including alkaloids, flavonoids, glycosides, terpenoids, fatty acids, and phenolic compounds. These compounds have been associated with various pharmacological properties, particularly antioxidant, anti-inflammatory, antimicrobial, cytotoxic, and antitumor activities. Therefore, Thalictrum minus, a species that is widely distributed in Mongolia but whose chemical composition and biological activities have not yet been comprehensively investigated, was selected for the present study. Aim: To determine total phenolic and flavonoid content of crude extracts of this plant. To investigate the antioxidant activity. Materials and Methods: Total phenolic compounds, total flavonoids and antioxidant activity were determined using spectrophotometer methods using extracts from the aerial parts of T. minus. Dried flowering plant material of Thalictrum minus, taxonomically identified by the Botanical Garden of the Mongolian Academy of Sciences, was obtained from the Department of Pharmaceutical Technology, Mongolian University of Pharmaceutical Sciences. Total phenolic content (TPC) was determined using the Folin–Ciocalteu method, with gallic acid as the reference standard, and absorbance was measured at 760 nm. Total flavonoid content (TFC) was determined using an aluminum chloride colorimetric assay, with rutin as the reference standard, and absorbance was measured at 500 nm. Antioxidant activity was evaluated using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical-scavenging assay. Plant extracts at different concentrations were mixed with DPPH solution and incubated in the dark for 30 min. Absorbance was measured at 517 nm using an Agilent BioTek Epoch 2 microplate reader, with quercetin as the positive control. Radical-scavenging activity was calculated as a percentage, and IC₅₀ values were determined from concentration–response curves. All measurements were performed in triplicate or quadruplicate, and results were expressed as IC₅₀±standard deviation (SD). Results: The total phenolic, total flavonoid content and antioxidant activity of the aerial parts of T. minus, a plant species growing in Mongolia, were evaluated using spectrophotometric methods. The total phenolic content of the aerial parts of Thalictrum minus L. was determined using gallic acid as the reference standard. The absorbance was measured at 500 nm, and the content was calculated using the calibration equation (y=0.6947x + 0.0046, R²=0.9997), yielding a total phenolic content of 5.38±0.09%. The total flavonoid content was determined using rutin as the reference standard and calculated using the calibration equation (y=0.3089x +0.0112, R²=0.9960), yielding a content of 2.04±0.16%. The antioxidant activity of the aerial-part extract was evaluated using the DPPH free-radical scavenging assay, which yielded an IC₅₀ value of 66.09 µg/mL. Conclusion The contents of selected bioactive secondary metabolites in the aerial parts of Thalictrum minus were determined. In addition, the antioxidant activity of the aerial-part extracts was evaluated in comparison with reference standards, demonstrating that the extracts possess antioxidant activity.

Background: Colorectal cancer (CRC) is one of the leading causes of cancer-related morbidity and mortality worldwide and develops through the accumulation of genetic alterations involving multiple genes. In Mongolia, the substantial burden of CRC, limited treatment options, and scarcity of studies investigating its molecular genetic characteristics highlight the need to improve molecular diagnostics and expand personalized treatment options. Aim: To identify genetic variants in tumor tissues from patients with CRC and compare them with variants detected in matched adjacent normal tissues. Materials and Methods: This cross-sectional study was conducted between August 2023 and May 2024 in collaboration with the National Cancer Center of Mongolia, the Mongolian Institute of Human Genetics, and Happy Veritas Hospital. Eleven patients who underwent surgical treatment for CRC at the Department of General Surgery were enrolled. Paired tumor and adjacent normal tissue samples were collected from each patient and analyzed. Targeted next-generation sequencing (NGS) was performed using the MGISEQ-200 platform, covering 2,881 targeted positions across 53 cancer-associated genes. Sequencing data were processed through a bioinformatics pipeline involving quality control, alignment to the reference genome, variant calling, and filtering. BWA-MEM, GATK Mutect2, and Variant Effect Predictor (VEP) were used to identify and annotate genetic variants. Variants were comparatively evaluated according to their occurrence in tumor and adjacent normal tissues, potential functional consequences, and clinical significance. Results: A total of 60 genetic variant observations were identified across 11 paired CRC and adjacent normal tissue samples, including 56 single-nucleotide variants (SNVs; 93.3%) and four insertions or deletions (INDELs; 6.7%). Of these, 36 observations (60.0%) were recorded in tumor tissues and 24 (40.0%) in adjacent normal tissues. Eleven amino acid-altering variants were identified in tumor tissues. Variants in PDGFRA (90.9%), TP53 (54.5%), APC (36.4%), PTEN (27.3%), KIT (18.2%), and KRAS (9.1%) were detected in tumor tissues. The frequencies of variants in PDGFRA, TP53, and PTEN were higher in tumor tissues than in adjacent normal tissues, although the differences were not statistically significant (p > 0.05; FDR ≥ 0.75). Variants detected in APC, KRAS, TP53, PTEN, and MLH1 were associated with molecular pathways involved in colorectal carcinogenesis, including Wnt/β-catenin, MAPK, p53, PI3K–AKT–mTOR, and DNA mismatch repair pathways. The KRAS p.Gly13Asp (G13D) variant was identified as a clinically relevant alteration for evaluating response to anti-EGFR targeted therapy. Conclusion Variants in PDGFRA, TP53, and PTEN were more frequently observed in CRC tissues than in adjacent normal tissues; however, the differences were not statistically significant. Variants in KRAS, KIT, and CDKN2A were detected exclusively in tumor tissues. The KRAS p.Gly13Asp variant may have clinical relevance in evaluating the selection of anti-EGFR targeted therapy.